1. Defective DNAM-1 Dependent Cytotoxicity in Hepatocellular Carcinoma-Infiltrating NK Cells
   Stefania Mantovani et al, 2022, Cancers CrossRef
2. Diverging prognostic effects of CD155 and CD73 expressions in locally advanced triple-negative breast cancer
   Neslihan Cabioglu et al, 2023, Frontiers in Oncology CrossRef
3. Fine-Tuning the Tumour Microenvironment: Current Perspectives on the Mechanisms of Tumour Immunosuppression
   Jesse D. Armitage et al, 2021, Cells CrossRef
4. TIGIT/CD226 Axis Regulates Anti-Tumor Immunity
   Jinah Yeo et al, 2021, Pharmaceuticals CrossRef
5. Primary Resistance to Immunotherapy-Based Regimens in First Line Hepatocellular Carcinoma: Perspectives on Jumping the Hurdle
   Francesca Salani et al, 2022, Cancers CrossRef
6. Integrated bioinformatic analysis and cell line experiments reveal the significant role of the novel immune checkpoint TIGIT in kidney renal clear cell carcinoma
   Qi-Dong Xia et al, 2023, Frontiers in Oncology CrossRef
7. TIGIT signaling and its influence on T cell metabolism and immune cell function in the tumor microenvironment
   Nouria Jantz-Naeem et al, 2023, Frontiers in Oncology CrossRef
8. PVR (CD155) Expression as a Potential Prognostic Marker in Multiple Myeloma
   Byung-Hyun Lee et al, 2022, Biomedicines CrossRef
9. Aberrant expression of junctional adhesion molecule‐A contributes to the malignancy of cervical adenocarcinoma by interaction with poliovirus receptor/CD155
   Taro Murakami et al, 2021, Cancer Science CrossRef
10. Immunmodulatory Treatment Strategies of Hepatocellular Carcinoma: From Checkpoint Inhibitors Now to an Integrated Approach in the Future
    Matthias Ocker et al, 2021, Cancers CrossRef
11. Role of CD155/TIGIT in Digestive Cancers: Promising Cancer Target for Immunotherapy
    Daijun Wang et al, 2022, Frontiers in Oncology CrossRef
12. Peptide-based PET imaging agent of tumor TIGIT expression
    Dinghu Weng et al, 2023, EJNMMI Research CrossRef
13. Immune-Based Combination Therapies for Advanced Hepatocellular Carcinoma
    Riccardo Carloni et al, 2023, Journal of Hepatocellular Carcinoma CrossRef
14. A novel scoring system for TIGIT expression in classic Hodgkin lymphoma
    Ombretta Annibali et al, 2021, Scientific Reports CrossRef
15. Prognostic Role of TIGIT Expression in Patients with Solid Tumors: A Meta-Analysis
    Kunmin Xiao et al, 2021, Journal of Immunology Research CrossRef
16. Cutting-Edge: Preclinical and Clinical Development of the First Approved Lag-3 Inhibitor
    Luisa Chocarro et al, 2022, Cells CrossRef
17. Hitting the complexity of the TIGIT-CD96-CD112R-CD226 axis for next-generation cancer immunotherapy
    Hyung-seung Jin et al, 2021, BMB Reports CrossRef